Vanguard Capital Wealth Advisors - NAUTILUS BIOTECHNOLOGY INC ownership

NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108. A total of 82 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Vanguard Capital Wealth Advisors ownership history of NAUTILUS BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$145,360
-36.6%
46,000
-25.2%
0.14%
-35.1%
Q2 2023$229,268
+9.6%
61,500
-18.5%
0.21%0.0%
Q1 2023$209,135
+405.2%
75,500
+228.3%
0.21%
+333.3%
Q4 2022$41,400
-13.8%
23,000
+2.2%
0.05%
-17.2%
Q3 2022$48,000
-26.2%
22,500
-7.0%
0.06%
-20.5%
Q2 2022$65,000
-43.5%
24,200
-9.4%
0.07%
-11.0%
Q1 2022$115,000
-51.1%
26,700
-41.3%
0.08%
-51.5%
Q4 2021$235,00045,5000.17%
Other shareholders
NAUTILUS BIOTECHNOLOGY INC shareholders Q4 2022
NameSharesValueWeighting ↓
Madrona Venture Group, LLC 6,020,770$30,663,0004.08%
Ally Bridge Group (NY) LLC 1,500,000$9,210,0002.71%
AMAZON COM INC 1,457,055$8,946,0001.82%
Affinity Asset Advisors, LLC 975,000$5,987,0001.51%
Tikvah Management LLC 708,540$4,350,436,0001.18%
Perceptive Advisors 8,911,151$54,714,0000.80%
Bain Capital Life Sciences Investors, LLC 2,000,000$12,280,0000.76%
HILLMAN CO 200,000$1,228,0000.43%
SPHERA FUNDS MANAGEMENT LTD. 800,000$4,912,0000.41%
RA Capital Management 2,436,430$14,960,0000.21%
View complete list of NAUTILUS BIOTECHNOLOGY INC shareholders